EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
DM014-02352 
Organism
Drosophila melanogaster 
Tissue/cell
L3_eye_ante_discs 
Coordinate
chr2L:14430935-14431832 
Target genes
Number: 23             
NameEnsembl ID
TF binding sites/motifs
Number: 34             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
BEAF-32MA0529.1chr2L:14431256-14431270ATCGATGGCTTTTT-4.57
CG18599MA0177.1chr2L:14431348-14431354TAATTA+4.01
CG18599MA0177.1chr2L:14431349-14431355AATTAG-4.01
CG9876MA0184.1chr2L:14431348-14431354TAATTA+4.01
CG9876MA0184.1chr2L:14431349-14431355AATTAG-4.01
CTCFMA0531.1chr2L:14431492-14431506TAAATGGGGGCGCT+4.17
E5MA0189.1chr2L:14431348-14431354TAATTA+4.01
E5MA0189.1chr2L:14431349-14431355AATTAG-4.01
Lim3MA0195.1chr2L:14431348-14431354TAATTA+4.01
Lim3MA0195.1chr2L:14431349-14431355AATTAG-4.01
MadMA0535.1chr2L:14431166-14431180TTCGCTGGCGTGAG-4.09
OdsHMA0198.1chr2L:14431348-14431354TAATTA+4.01
OdsHMA0198.1chr2L:14431349-14431355AATTAG-4.01
PHDPMA0457.1chr2L:14431348-14431354TAATTA+4.01
PHDPMA0457.1chr2L:14431349-14431355AATTAG-4.01
Pph13MA0200.1chr2L:14431348-14431354TAATTA+4.01
Pph13MA0200.1chr2L:14431349-14431355AATTAG-4.01
RxMA0202.1chr2L:14431348-14431354TAATTA+4.01
RxMA0202.1chr2L:14431349-14431355AATTAG-4.01
Vsx2MA0180.1chr2L:14431348-14431356TAATTAGC-4.53
apMA0209.1chr2L:14431348-14431354TAATTA+4.01
apMA0209.1chr2L:14431349-14431355AATTAG-4.01
dveMA0915.1chr2L:14430942-14430949GGATTAT-4.18
eveMA0221.1chr2L:14431130-14431136TAATGA+4.1
exdMA0222.1chr2L:14431650-14431657TTTGACA+4.1
indMA0228.1chr2L:14431348-14431354TAATTA+4.01
indMA0228.1chr2L:14431349-14431355AATTAG-4.01
nubMA0197.2chr2L:14430995-14431006ATTTAAATAAT+4.43
pnrMA0536.1chr2L:14431253-14431263ATCATCGATG-4.03
pnrMA0536.1chr2L:14431256-14431266ATCGATGGCT+4.56
roMA0241.1chr2L:14431348-14431354TAATTA+4.01
roMA0241.1chr2L:14431349-14431355AATTAG-4.01
uspMA0016.1chr2L:14431797-14431806TGGTCACCG+4.25
zenMA0256.1chr2L:14431130-14431136TAATGA+4.1
Enhancer Sequence
TTTGAACGGA TTATTACGAT TTTTGCTCTG CTCGTTGTTC CCAACAAAAA TGGAGAGAAT 60
ATTTAAATAA TCTCGAACTA TTTGTATGTA ACGATAAAAC CAGGTATTTC TTTAAATTAC 120
TGAATGAGAG TATGAGTTAT ATGTTACGCT ATATTTTGTT GTGTAAGAAT TTTGTATTTT 180
TTGTGTGAGA TCGACTAATG ACTGAAACTA AACCCTTGAT GCTTGGTCAT GTTCGCTGGC 240
GTGAGATTTC CTGCTTTCAT CAAACTGAGA CCTGGCCAAA GGTTCCACCA GTTCCTATTA 300
GTATTGAATT TCGCTAAAAT CATCGATGGC TTTTTACAGG GATATACATA CGAGGTAAAT 360
TAGGGTTGAC CCACTCCAAC CCGTGACATG GCTCTCAATC AGAACTGGGC ACCTAATTAG 420
CTCTTGGTTT TAGGGCTCGA GGTATCAATT TTCCCTGTTT CGCATCGAGT AACACATACA 480
TATGTGGCAA TGTCTGGTAA ATGTATTTGG AAAAAAGGGA CCAATTTCCA GAGTCCTGTG 540
CCACCTTTTT GCCCACCTAA ATGGGGGCGC TAATCTCTGC AACAGAGATT AACAGCCGAG 600
CAGACACAGA AACCAATTTT GTGTGCCGGC CAACTGCCGG CCAGGCAGGA AGGCAGAATG 660
GCTCTTGGTC GAGTGACAGC AGCCAGAAGG CCTAAATTTA CGGCTTTCTG GGTAATTTGA 720
CACTTCGGAC AGAATAAACG AGTGGAATGA GAGCCGCCAG GAAGAAAGGG AGCGGATAGT 780
CATTGCAGCA CAGGACATGG GACATATTAC GAGGGTTAGG TCCTGTAGGG ATATGGGTTC 840
GAACTGGTCG AGGTCGGACC TGTGGTCACC GAGTGTCAAT TGATCACAGA CGTCTGC 897